Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Outer Retinal Assessment Using Spectral-Domain Optical Coherence Tomography in Patients With Alzheimer's and Parkinson's Disease.

Uchida A, Pillai JA, Bermel R, Bonner-Jackson A, Rae-Grant A, Fernandez H, Bena J, Jones SE, Leverenz JB, Srivastava SK, Ehlers JP.

Invest Ophthalmol Vis Sci. 2018 Jun 1;59(7):2768-2777. doi: 10.1167/iovs.17-23240.

2.

Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Rae-Grant A, Day GS, Marrie RA, Rabinstein A, Cree BAC, Gronseth GS, Haboubi M, Halper J, Hosey JP, Jones DE, Lisak R, Pelletier D, Potrebic S, Sitcov C, Sommers R, Stachowiak J, Getchius TSD, Merillat SA, Pringsheim T.

Neurology. 2018 Apr 24;90(17):789-800. doi: 10.1212/WNL.0000000000005345.

PMID:
29686117
3.

Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Rae-Grant A, Day GS, Marrie RA, Rabinstein A, Cree BAC, Gronseth GS, Haboubi M, Halper J, Hosey JP, Jones DE, Lisak R, Pelletier D, Potrebic S, Sitcov C, Sommers R, Stachowiak J, Getchius TSD, Merillat SA, Pringsheim T.

Neurology. 2018 Apr 24;90(17):777-788. doi: 10.1212/WNL.0000000000005347.

PMID:
29686116
4.

Extreme delta - With or without brushes: A potential surrogate marker of disease activity in anti-NMDA-receptor encephalitis.

Steriade C, Hantus S, Moosa ANV, Rae-Grant AD.

Clin Neurophysiol. 2018 Mar 10. pii: S1388-2457(18)30239-6. doi: 10.1016/j.clinph.2018.02.130. [Epub ahead of print]

PMID:
29580710
5.

Transient neurologic syndromes: A diagnostic approach.

Abbatemarco JR, Rae-Grant AD.

Cleve Clin J Med. 2018 Feb;85(2):155-163. doi: 10.3949/ccjm.85a.17022. Review.

6.

Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Petersen RC, Lopez O, Armstrong MJ, Getchius TSD, Ganguli M, Gloss D, Gronseth GS, Marson D, Pringsheim T, Day GS, Sager M, Stevens J, Rae-Grant A.

Neurology. 2018 Jan 16;90(3):126-135. doi: 10.1212/WNL.0000000000004826. Epub 2017 Dec 27.

PMID:
29282327
7.

Outcomes of Bariatric Surgery in Morbidly Obese Patients with Multiple Sclerosis.

Bencsath K, Jammoul A, Aminian A, Shimizu H, Fisher CJ, Schauer PR, Rae-Grant A, Brethauer SA.

J Obes. 2017;2017:1935204. doi: 10.1155/2017/1935204. Epub 2017 Feb 19.

8.

Antidepressant Drug Treatment in Association with Multiple Sclerosis Disease-Modifying Therapy: Using Explorys in the MS Population.

Mirsky MM, Marrie RA, Rae-Grant A.

Int J MS Care. 2016 Nov-Dec;18(6):305-310. doi: 10.7224/1537-2073.2016-056.

9.

Clinical utility of seropositive voltage-gated potassium channel-complex antibody.

Jammoul A, Shayya L, Mente K, Li J, Rae-Grant A, Li Y.

Neurol Clin Pract. 2016 Oct;6(5):409-418.

10.

Author Response.

Bennett A, Rae-Grant A, Bever C.

Neurology. 2016 Apr 5;86(14):1361. No abstract available.

PMID:
27500299
11.

Quality improvement in neurology: Multiple sclerosis quality measures: Executive summary.

McDonnell GV, Bennett A, Rae-Grant A, Bever C.

Neurology. 2016 Apr 5;86(14):1361. doi: 10.1212/WNL.0000000000002578. No abstract available.

PMID:
27044615
12.

A clinical approach to diagnosis of autoimmune encephalitis.

Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, Cortese I, Dale RC, Gelfand JM, Geschwind M, Glaser CA, Honnorat J, Höftberger R, Iizuka T, Irani SR, Lancaster E, Leypoldt F, Prüss H, Rae-Grant A, Reindl M, Rosenfeld MR, Rostásy K, Saiz A, Venkatesan A, Vincent A, Wandinger KP, Waters P, Dalmau J.

Lancet Neurol. 2016 Apr;15(4):391-404. doi: 10.1016/S1474-4422(15)00401-9. Epub 2016 Feb 20. Review.

13.

Retinal Nerve Fiber Layer Thinning in Alzheimer's Disease: A Case-Control Study in Comparison to Normal Aging, Parkinson's Disease, and Non-Alzheimer's Dementia.

Pillai JA, Bermel R, Bonner-Jackson A, Rae-Grant A, Fernandez H, Bena J, Jones SE, Ehlers JP, Leverenz JB.

Am J Alzheimers Dis Other Demen. 2016 Aug;31(5):430-6. doi: 10.1177/1533317515628053. Epub 2016 Feb 16.

PMID:
26888864
14.

Autoantibody-mediated encephalitis: Not just paraneoplastic, not just limbic, and not untreatable.

Jammoul A, Li Y, Rae-Grant A.

Cleve Clin J Med. 2016 Jan;83(1):43-53. doi: 10.3949/ccjm.83a.14112. Review.

15.

Summary of comprehensive systematic review: Rehabilitation in multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Haselkorn JK, Hughes C, Rae-Grant A, Henson LJ, Bever CT, Lo AC, Brown TR, Kraft GH, Getchius T, Gronseth G, Armstrong MJ, Narayanaswami P.

Neurology. 2015 Nov 24;85(21):1896-903. doi: 10.1212/WNL.0000000000002146. Review.

16.

Quality improvement in neurology: Multiple sclerosis quality measures: Executive summary.

Rae-Grant A, Bennett A, Sanders AE, Phipps M, Cheng E, Bever C.

Neurology. 2015 Nov 24;85(21):1904-8. doi: 10.1212/WNL.0000000000001965. Epub 2015 Sep 2. Review. No abstract available. Erratum in: Neurology. 2016 Apr 12;86(15):1465.

17.

No Association of Chronic Cerebrospinal Venous Insufficiency with Multiple Sclerosis.

Fox RJ, Diaconu C, Baus L, Grattan A, Katzan I, Lee JC, Raber L, Rae-Grant A, Ramesh S, Lu M, Kim ESh.

Can J Neurol Sci. 2016 Jan;43(1):195-7. doi: 10.1017/cjn.2015.245. Epub 2015 Jul 21. No abstract available.

PMID:
26194114
18.

Chronic cerebrospinal venous insufficiency: pitfalls and perils of sonographic assessment.

Kim ES, Diaconu C, Baus L, Fox RJ, Grattan A, Katzan I, Raber L, Rae-Grant A, Lu M.

J Ultrasound Med. 2015 Jun;34(6):1097-106. doi: 10.7863/ultra.34.6.1097.

PMID:
26014330
19.

Observations on the brain vasculature in multiple sclerosis: A historical perspective.

Rae-Grant AD, Wong C, Bernatowicz R, Fox RJ.

Mult Scler Relat Disord. 2014 Mar;3(2):156-62. doi: 10.1016/j.msard.2013.08.005. Epub 2013 Dec 19. Review.

PMID:
25878003
20.

Clinical experience of seropositive ganglionic acetylcholine receptor antibody in a tertiary neurology referral center.

Li Y, Jammoul A, Mente K, Li J, Shields RW, Vernino S, Rae-Grant A.

Muscle Nerve. 2015 Sep;52(3):386-91. doi: 10.1002/mus.24559. Epub 2015 Jun 30.

PMID:
25557122
21.

A systematic review of stress-management interventions for multiple sclerosis patients.

Reynard AK, Sullivan AB, Rae-Grant A.

Int J MS Care. 2014 Fall;16(3):140-4. doi: 10.7224/1537-2073.2013-034.

22.

Hydration status substantially affects chronic cerebrospinal venous insufficiency assessments.

Diaconu CI, Fox RJ, Grattan A, Rae-Grant A, Lu M, Gornik HL, Kim ES.

Neurol Clin Pract. 2013 Oct;3(5):386-391.

23.

Unusual symptoms and syndromes in multiple sclerosis.

Rae-Grant AD.

Continuum (Minneap Minn). 2013 Aug;19(4 Multiple Sclerosis):992-1006. doi: 10.1212/01.CON.0000433287.30715.07. Review.

PMID:
23917097
24.

Evidence-based guideline: IV immunoglobulin in the treatment of neuromuscular disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Li HF, Gao X, Hong Y, Patwa HS, Chaudhry V, Rae-Grant AD, So YT, Alto P.

Neurology. 2012 Sep 25;79(13):1411; author reply 1411. No abstract available.

25.

A technical approach to dissecting and assessing cadaveric veins pertinent to chronic cerebrospinal venous insufficiency in multiple sclerosis.

Diaconu CI, Staugaitis SM, Fox RJ, Rae-Grant A, Schwanger C, McBride JM.

Neurol Res. 2012 Oct;34(8):810-8. doi: 10.1179/1743132812Y.0000000071.

26.

Extended-release dalfampridine in the management of multiple-sclerosis-related walking impairment.

Hersh C, Rae-Grant A.

Ther Adv Neurol Disord. 2012 Jul;5(4):199-204. doi: 10.1177/1756285612447091.

27.

Evidence-based guideline: intravenous immunoglobulin in the treatment of neuromuscular disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Patwa HS, Chaudhry V, Katzberg H, Rae-Grant AD, So YT.

Neurology. 2012 Mar 27;78(13):1009-15. doi: 10.1212/WNL.0b013e31824de293. Review.

PMID:
22454268
28.

Chronic cerebrospinal venous insufficiency as a cause of multiple sclerosis: controversy and reality.

Diaconu CI, Conway D, Fox RJ, Rae-Grant A.

Curr Treat Options Cardiovasc Med. 2012 Apr;14(2):203-14. doi: 10.1007/s11936-012-0168-7.

PMID:
22311713
29.

Self-management in neurological disorders: systematic review of the literature and potential interventions in multiple sclerosis care.

Rae-Grant AD, Turner AP, Sloan A, Miller D, Hunziker J, Haselkorn JK.

J Rehabil Res Dev. 2011;48(9):1087-100. Review.

30.

Chronic cerebrospinal venous insufficiency: have we found the cause and cure of MS?

Fox RJ, Rae-Grant A.

Neurology. 2011 Jul 12;77(2):98-100. doi: 10.1212/WNL.0b013e318212a915. Epub 2011 Apr 13. No abstract available.

PMID:
21490321
31.

Evidence-based guideline update: Plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Cortese I, Chaudhry V, So YT, Cantor F, Cornblath DR, Rae-Grant A.

Neurology. 2011 Jan 18;76(3):294-300. doi: 10.1212/WNL.0b013e318207b1f6. Review.

32.

Diagnosing multiple sclerosis at a later age: more than just progressive myelopathy.

Bermel RA, Rae-Grant AD, Fox RJ.

Mult Scler. 2010 Nov;16(11):1335-40. doi: 10.1177/1352458510377334. Epub 2010 Jul 29.

PMID:
20670982
33.

Management of acute exacerbations in multiple sclerosis.

Ontaneda D, Rae-Grant AD.

Ann Indian Acad Neurol. 2009 Oct;12(4):264-72. doi: 10.4103/0972-2327.58283.

34.

Advances in the immune pathogenesis and treatment of multiple sclerosis.

Huang D, Rae-Grant A.

Cent Nerv Syst Agents Med Chem. 2009 Mar;9(1):20-31.

PMID:
20021335
35.

Neurodegeneration and neuroprotective agents in multiple sclerosis.

Fong JS, Rae-Grant A, Huang D.

Recent Pat CNS Drug Discov. 2008 Nov;3(3):153-65. Review.

PMID:
18991805
36.

Diagnosis and neuroimaging of acute stroke producing distal arm monoparesis.

Castaldo J, Rodgers J, Rae-Grant A, Barbour P, Jenny D.

J Stroke Cerebrovasc Dis. 2003 Nov-Dec;12(6):253-8.

PMID:
17903936
37.

Pure monoparesis: what makes it different.

Isayev Y, Castaldo J, Rae-Grant A, Barbour P.

Arch Neurol. 2006 May;63(5):786; author reply 786. No abstract available.

PMID:
16682556
38.

The vibration quantitation scale (VQS): a simple, reproducible bedside measure of sensory function in multiple sclerosis.

Carter J, Wasser T, Statler S, Rae-Grant AD.

Can J Neurol Sci. 2004 Nov;31(4):490-3.

PMID:
15595253
39.

Welcome 2000: concern for the patient, collaboration with colleagues, and confidence for the future.

Rae-Grant Q, Rae-Grant AD.

Can J Psychiatry. 2000 Feb;45(1):28-9. No abstract available.

PMID:
10696486
40.

Sensory symptoms of multiple sclerosis: a hidden reservoir of morbidity.

Rae-Grant AD, Eckert NJ, Bartz S, Reed JF.

Mult Scler. 1999 Jun;5(3):179-83.

PMID:
10408718
41.

A reversible cause of hypercapnic respiratory failure: lower motor neuronopathy associated with renal cell carcinoma.

Forman D, Rae-Grant AD, Matchett SC, Cowen JS.

Chest. 1999 Mar;115(3):899-901.

PMID:
10084515
42.

Outcome of severe brain injury: a multimodality neurophysiologic study.

Rae-Grant AD, Eckert N, Barbour PJ, Castaldo JE, Gee W, Wohlberg CJ, Lin ZS, Reed JF 3rd.

J Trauma. 1996 Mar;40(3):40l-7.

PMID:
8601857
43.

Differentiation of alpha coma from awake alpha by nonlinear dynamics of electroencephalography.

Kim YW, Krieble KK, Kim CB, Reed J, Rae-Grant AD.

Electroencephalogr Clin Neurophysiol. 1996 Jan;98(1):35-41.

PMID:
8689992
44.

Internal carotid artery redundancy is significantly associated with dissection.

Barbour PJ, Castaldo JE, Rae-Grant AD, Gee W, Reed JF 3rd, Jenny D, Longennecker J.

Stroke. 1994 Jun;25(6):1201-6.

PMID:
8202980
45.

Primary angiitis of the central nervous system: unusual MR appearance.

Shoemaker EI, Lin ZS, Rae-Grant AD, Little B.

AJNR Am J Neuroradiol. 1994 Feb;15(2):331-4.

PMID:
8192081
46.

Type III intermittency: a nonlinear dynamic model of EEG burst suppression.

Rae-Grant AD, Kim YW.

Electroencephalogr Clin Neurophysiol. 1994 Jan;90(1):17-23.

PMID:
7509270
47.

Development of a novel EEG rating scale for head injury using dichotomous variables.

Rae-Grant AD, Barbour PJ, Reed J.

Electroencephalogr Clin Neurophysiol. 1991 Nov;79(5):349-57.

PMID:
1718707
48.

Alzheimer's disease in Down's syndrome with SPECT.

Rae-Grant AD, Barbour PJ, Sirotta P, Gross P.

Clin Nucl Med. 1991 Jul;16(7):509-10.

PMID:
1834388
49.

A private practice model for teaching and research activities.

Levitt LP, Barbour PJ, Castaldo JE, Rae-Grant AD.

J Neurol Sci. 1991 May;103(1):105-8.

PMID:
1865224
50.

Episodic low-amplitude events: an under-recognized phenomenon in clinical electroencephalography.

Rae-Grant AD, Strapple C, Barbour PJ.

J Clin Neurophysiol. 1991 Apr;8(2):203-11.

PMID:
2050820

Supplemental Content

Loading ...
Support Center